Evidence map›Paper›PMID 34611142›Full record

ArticleCell death & disease2021

Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer's disease.

Chiara Burgaletto, Chiara Bianca Maria Platania, Giulia Di Benedetto, Antonio Munafò, Giovanni Giurdanella, Concetta Federico, Rosario Caltabiano, Salvatore Saccone, Federica Conti, Renato Bernardini and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Chiara Burgaletto *Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.ORCID 0000-0002-5517-8223
Chiara Bianca Maria Platania *Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
Giulia Di BenedettoDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
Antonio MunafòDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
Giovanni GiurdanellaDepartment of Biomedical and Biotechnological Sciences, Section of Biochemistry, University of Catania School of Medicine, Catania, Italy.
Concetta FedericoDepartment of Biological, Geological and Environmental Sciences, Section of Animal Biology, University of Catania, Catania, Italy.
Rosario CaltabianoDepartment Gian Filippo Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, Italy.
Salvatore SacconeDepartment of Biological, Geological and Environmental Sciences, Section of Animal Biology, University of Catania, Catania, Italy.
Federica ContiDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
Renato BernardiniDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy. bernardi@unict.it.ORCID 0000-0002-4765-0663
Claudio BucoloDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
Giuseppina CantarellaDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania School of Medicine, Catania, Italy.
University of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related disorders, such as Alzheimer's disease (AD) and age-related macular degeneration (AMD) share common features such as amyloid-β (Aβ) protein accumulation. Retinal deposition of Aβ aggregates in AMD patients has suggested a potential link between AMD and AD. In the present study, we analyzed the expression pattern of a focused set of miRNAs, previously found to be involved in both AD and AMD, in the retina of a triple transgenic mouse model of AD (3xTg-AD) at different time-points. Several miRNAs were differentially expressed in the retina of 3xTg-AD mice, compared to the retina of age-matched wild-type (WT) mice. In particular, bioinformatic analysis revealed that miR-155 had a central role in miRNA-gene network stability, regulating several pathways, including apoptotic and inflammatory signaling pathways modulated by TNF-related apoptosis-inducing ligand (TNFSF10). We showed that chronic treatment of 3xTg-AD mice with an anti-TNFSF10 monoclonal antibody was able to inhibit the retinal expression of miR-155, which inversely correlated with the expression of its molecular target SOCS-1. Moreover, the fine-tuned mechanism related to TNFSF10 immunoneutralization was tightly linked to modulation of TNFSF10 itself and its death receptor TNFRSF10B, along with cytokine production by microglia, reactive gliosis, and specific AD-related neuropathological hallmarks (i.e., Aβ deposition and Tau phosphorylation) in the retina of 3xTg-AD mice. In conclusion, immunoneutralization of TNFSF10 significantly preserved the retinal tissue in 3xTg-AD mice, suggesting its potential therapeutic application in retinal degenerative disorders.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAntibodies, NeutralizingBase SequenceCalcium-Binding ProteinsCyclooxygenase 2Disease Models, AnimalDown-RegulationGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksGlial Fibrillary Acidic ProteinGliosisInflammationInterleukin-10Aif1 protein, mouseAmyloid beta-PeptidesAntibodies, NeutralizingCalcium-Binding ProteinsCyclooxygenase 2Glial Fibrillary Acidic ProteinInterleukin-10Microfilament ProteinsMicroRNAsMirn155 microRNA, mouseReceptors, TNF-Related Apoptosis-Inducing LigandSocs1 protein, mouseSuppressor of Cytokine Signaling 1 Proteintau ProteinsTNF-Related Apoptosis-Inducing LigandTNFRSF10B protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID34611142
PMCPMC8492692
OpenAlexW3203954720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.